|
| CMN-0001-26 | 06/03/2026 | SCM | Permanent | Major | New source induction of Ascorbic Acid as Excipient. | Currently we have approved sources for Ascorbic Acid Coated 97% and no any approved source for Ascorbic Acid. | We intend to induct new source for Ascorbic Acid as Excipient M/s. Heilongjiang NHU Biotechnology CO., Ltd. Address: No 2. Haotian Road, Economic and Technological Development Zone, Suihua, Heilongjiang China. | N/A | Approved | 31/05/2026 | In Progress | Nutra | 01) Source approval documents will be submitted to QA. (SCM)
02) Procurement of material from new source. (SCM)
03) Vendor list will be update. (QA)
04) source name will be added in SAP. (QA)
|
| 01) March-26
02) May-26
03) May-26
04) May-26
| Muhammad Haris | 06/03/2026 | Muhammad Haris | 18/03/2026 |
|
| CMN-0002-26 | 12/03/2026 | PD | Permanent | | Change of specification of Quatrefolic in Finno-Q Sachet. | Currently shelf life specification of finished product is 90-140% containing 50% overage of Quatrefolic. | Revising the shelf life specification of Quatrefolic to 90-160%. | N/A | Approved | | In Progress | Nutra | 01) Testing method will be revise. (QC)
02) Specification will be update in SAP. (QC)
|
| 01) April-26
02) April-26
| Muhammad Haris | 12/03/2026 | Muhammad Haris | 08/04/2026 |
|
| CMN-0003-26 | 30/03/2026 | PD | Permanent | Moderate | Launch of New Product in Jordan. | The products mentioned below are not launched in Jordan yet.
S.No: 01. Products: Supercran Sachet. Generic: Cranberry Extract. Pack Size: 1x10's. Shelf Life: 24 months. Registration Timeline: May-26. | These products are planned for launch in Jordan. | N/A | Approved | 30/08/2026 | In Progress | Nutra | 01) Registration is required. (RA)
02) Product launch in Jordan. (BD)
03) Development and approval of artwork. (BD)
04) Item code of packaging material will be open. (BD)
05) FG code will be open. (SCM)
06) BOM will be create in SAP. (QA)
07) BPR will be prepare. (QA)
08) Procurement of packaging material. (SCM)
09) Specification will be develop in SAP. (QC)
|
| 01) June-26
02) Aug-26
03) Done
04) Done
05) April-26
06) Aug-26
07) Aug-26
08) Based on sales order.
09) Aug-26
| Muhammad Haris | 30/03/2026 | Muhammad Haris | 23/04/2026 |
|
| CMN-0004-26 | 22/06/2026 | QA | Permanent | | Induction of new Instrument Moisture Analyzer MA 110.R. WH Radwag with Printer in IPC Lab Nutra Section | Currently, no Moisture Analyzer available in IPC Lab Nutra | Induction of new Instrument Moisture Analyzer MA 110.R. WH Radwag with Printer in IPC Lab Nutra Section. | | Under Approval | | | Nutra |
|
|
| Muhammad Haris | 22/06/2026 | | |
|
| CMN-0005-26 | 01/07/2026 | PD | Permanent | Major | New launch product Iron 30mg/ Folate (Quaterfolic 1200mch):600mcg tablet. | Product development activities of generic Iron 30mg/ Folate (Quaterfolic 1200mcg): 600mcg tablet has been completed. | It is proposed to commercialize Iron 30mg/ Folate (Quaterfolic 1200mcg):600mcg tablet in PharmEvo facility.
Suggested batch size is 200,000 tablet (200.00Kg) | RA-0001-26-N | Approved | 31/08/2027 | In Progress | Nutra | 01) Trial documets are required. (PD)
02) Stability study documents are required. (PD)
03) Technology transfer protocol (for process) is required. (PD)
04) Technology transfer protocol (for analytical testing) is required. (PD)
05) PD will submit all material halal certificate. (PD)
06) Registration letter is required. (RA)
07) Source approval documents of Sorbitol will be submitted to QA. (SCM)
08) Procurement of Sorbitol. (SCM)
09) Artwork will be developed and approved. (BD)
10) Item codes will be opened for new developed artwork. (BD)
11) FG codes will be opened. (SCM)
12) Procurement of packaging material. (SCM)
13) Analytical testing method will be prepared. (QC)
14) BOM will be create in SAP. (QA)
15) Batch documents (BDR, BMR, BYS and BPR) will be prepared. (QA)
16) Routing will be create in SAP. (Production)
17) Planning of product launch for commercial. (BD)
18) Process validation will be perform. QA(Val)
19) Hold time study will be perform. QA(Val)
20) Product will be charge on stability. (QC)
21) Product will be halal certified. (QA)
|
| 01) Done
02) Done
03) Aug-26
04) Aug-26
05) Aug-26
06) Sep-26
07) Sep-26
08) Nov-26
09) Sep-26
10) Sep-26
11) Sep-26
12) Nov-26
13) Jan-27
14) Jan-27
15) Jan-27
16) Jan-27
17) Jan-27
18) Mar-27
19) Aug-27
20) March-27
21) Jan-27
| Muhammad Haris | 01/07/2026 | Muhammad Haris | 15/07/2026 |
|
| CMN-0006-26 | 01/07/2026 | PD | Permanent | Major | New launch product Elemental Iron 28mg/ Vitamic C 80mg/ Vitamin B12 2.5mcg Sachet. | Product development activities of generic Elemental Iron 28mg/ Vitamin C 80mg/ Vitamin B12 2.5mcg Sachet has been completed. | It is proposed to commercialize Elemental Iron 28mg/ Vitamin C 80mg/ Vitamin B12 2.5mcg Sachet in PharmEvo facility.
Suggested batch size is 60,000 sachet (180.00Kg) | RA-0002-26-N | Approved | 31/08/2027 | In Progress | Nutra | 01) Trial documents are required. (PD)
02) Stability study documents are required. (PD)
03) Technology transfer protocol (for process) is required. (PD)
04) Technology transfer protocol (for analytical testing) is required.
05) Registration letter is required. (RA)
06) Artwork will be developed and approved. (BD)
07) Item codes will be open for new developed artwork. (BD)
08) FG codes will be opened. (SCM)
09) Procurement of packaging material. (SCM)
10) Analytical testing method will be prepared. (QC)
11) BOM will be create in SAP. (QA)
12) Batch documents (BDR, BMR, BYS and BPR) will be prepared. (QA)
13) Routing will be create in SAP. (QA)
14) Planning of product launch for commercial. (BD)
15) Process validation will be performed. QA(Val)
16) Hold time study will be perform. QA(Val)
17) Product will be charge on stability. (QC)
18) Product will be halal certified. (QA)
|
| 01) Done
02) Done
03) Aug-26
04) Aug-26
05) Done
06) July-26
07) July-26
08) Aug-26
09) Oct-26
10) Dec-26
11) Dec-26
12) Dec-26
13) Dec-26
14) Dec-26
15) March-27
16) Aug-27
17) March-27
18) Dec-26
| Muhammad Haris | 01/07/2026 | Muhammad Haris | 15/07/2026 |